Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

TwinStrand Biosciences

Request full access

And commercializes the duplex sequencing™ technology for dna sequencing

Seattle, United StatesFounded 2015Biotech & Life Sciences

At a glance

Status
Operational
Employees
13
Open positions
None listed
Dealroom signal
70.0/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, DNA, Genetics and genomics, Spinout, Genome Engineering, Tech for Biotech and Pharma, Biotech and Pharma, DT and LS, science-based
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Jun 2023 $10M $250M Undisclosed ↗
SERIES BOther financing May 2021 $50M $200M Madrona Venture Group · Janus Henderson Investors · Ridgeback Capital · Soleus Capital —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

TwinStrand Biosciences website traffic

Latest recorded traffic for TwinStrand Biosciences is 1.5K monthly website visits, down 11.8% over the last three months. TwinStrand Biosciences's team declined 13.3% over the past year.

Latest monthly visits1.5K 3-month web change-11.8% 1-year team growth-13.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

TwinStrand Biosciences in the Seattle ecosystem

Live from Dealroom

The TwinStrand Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

Other known investors1 additional known investor

  • University of Washington
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about TwinStrand Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See TwinStrand Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.